Gemeenschapsmerk – Beroep door de aanvrager van het woordmerk „ROVI Pharmaceuticals” voor waren en diensten van de klassen 3, 5 en 44 ingesteld en strekkende tot vernietiging van beslissing R 500/20102 van de tweede kamer van beroep van het BHIM houdende verwerping van het beroep tegen de weigering van de oppositieafdeling om dit merk in te schrijven in het kader van de oppositie ingesteld door de houder van de nationale en gemeenschapswoord- en beeldmerken met de woordelementen „ROVI”, „ROVICM Rovi Contract Manufacturing” en „ROVIFARMA” voor waren en diensten van de klassen 1, 3, 5, 39, 42 en 44.
Het beroep wordt afgewezen. Het enkele feit dat het element ‘rovi’ in een groot aantal merken aanwezig is, leidt niet tot een verminderde gevaar voor verwarring.
99 It follows from the foregoing that the Board of Appeal did not err when it assessed the similarities between the mark applied for and the earlier word mark.
116 Furthermore, the applicant criticises the Board of Appeal on the ground that it assessed the distinctive character of the word element ‘rovi’ by examining whether earlier marks identical to the signs at issue coexisted on the market in such a way that the distinctive character of that element and, therefore, the likelihood of confusion between the signs at issue could be regarded as reduced. According to the applicant, the examination of the distinctive character of that element ought to have been based on the finding that it is present in a large number of marks. The applicant adds that the Board of Appeal erred in finding that it was for the applicant to establish that marks identical to the signs at issue coexisted on the market.
126 The applicant cannot therefore argue that the Board of Appeal did not take account of the absence of similarity between certain of the goods and services designated in the trade mark application and those covered by the earlier word mark when it examined whether there was a likelihood of confusion between those signs.
Lees het arrest hier.